Some people cannot use systemic hormone therapy, and some prefer not to. That does not mean they have to simply tolerate disruptive symptoms. The alternatives depend on the problem being treated and the person’s medical history.
Nonhormonal does not automatically mean risk-free. Prescription medicines, supplements and behavioral approaches have different evidence, side effects and monitoring requirements. Ask about the exact option instead of treating the category as a single safe substitute.
Match the option to the symptom
A treatment for hot flashes may not help vaginal dryness. A sleep strategy may improve rest without changing the frequency of vasomotor symptoms. Start by deciding which symptom is most disruptive and whether it needs additional investigation.
Clinicians may discuss nonhormonal prescription treatments for vasomotor symptoms, including selected medicines used for mood symptoms and newer targeted options. The indication, other medicines and health history determine which choices are reasonable. This article does not provide a regimen or rank medicines for an individual reader.
Veozah has specific liver-safety requirements
Fezolinetant, sold as Veozah, is a nonhormonal prescription treatment for moderate to severe vasomotor symptoms due to menopause. The FDA added a boxed warning about rare but serious liver injury. The agency describes blood testing before treatment, monthly for the first three months, and again at months six and nine.
That monitoring schedule is a reason to discuss logistics and cost before starting. Follow the current prescribing information and your clinician’s instructions. Symptoms such as jaundice, dark urine or significant new fatigue while taking the medicine need prompt attention under that plan; do not wait for a routine renewal visit.
Vaginal comfort has its own options
Lubricants may help with friction during sexual activity, and vaginal moisturizers may help ongoing dryness. Persistent pain, bleeding, discharge or urinary symptoms should be assessed rather than repeatedly treated with new over-the-counter products.
Low-dose vaginal estrogen is a hormonal local treatment, so it should not be called nonhormonal. It may still deserve a separate discussion when systemic therapy is unsuitable. The local-estrogen guide explains that distinction.
Be cautious with supplement promises
A product labeled natural can still cause side effects, interact with medicines or have inconsistent quality. Evidence for one standardized preparation cannot automatically be applied to another bottle with a similar ingredient list. Bring supplements to the medication review just as you would prescriptions.
A provider selling both prescriptions and supplements should be able to explain the evidence and the goal for each. Do not assume a supplement treats menopause because it is displayed next to a hormone medication or bundled into a membership.
Ask about access and follow-up
Evernow and Gennev describe nonhormonal care in their public menus. Confirm which options a clinician can actually offer in your state and whether laboratory monitoring or local care is needed.
If you are deciding against HRT because of a specific concern, bring that concern to the conversation. A clinician can explain whether it applies to systemic treatment, local treatment, a particular product or all hormone therapy in your situation. Our HRT basics can help frame the question.
FOLLOW THE EVIDENCE
Sources & further reading
Provider pages support service and price descriptions. Medical guidance supports treatment explanations. Neither is a first-hand review of patient outcomes. Checked September 20, 2026.